This can be explained by the differences in the quantity and quality of neutralizing antibodies against PT, antibody avidities, the timing of memory B-cell and T-cell immune responses against pertussis, or vaccine antigen-specific IgG subclass profiles induced [7,14,20,28,29,30]. The gene discussed is F2; the disease is pertussis.